Do You Need a Prescription for Compounded Semaglutide? (Yes — Here's Why) (2026)

Yes — you need a prescription. Compounded semaglutide is a prescription medication, just like brand-name Ozempic and Wegovy. Under federal law, semaglutide is a prescription-only drug, so a licensed prescriber — a physician, nurse practitioner, or physician assistant — must evaluate you and write the prescription, and a licensed compounding pharmacy must dispense it.^[1][2] There is no legal way to buy real compounded semaglutide without a prescription, and since FDA declared the semaglutide shortage over in February 2025, even a prescription only supports compounding in narrow, patient-specific circumstances.^[6] Any website offering "semaglutide — no prescription needed," "research-grade semaglutide," or vials labeled "research peptide, not for human consumption" is operating outside the law, and that is a serious safety red flag, not a shortcut. This guide explains how the legitimate process actually works, how to spot a real provider from a counterfeit one, and why the prescription step exists in the first place. This is general educational information, not medical or legal advice — a licensed clinician makes the prescribing decision for you.

The short answer: yes, a prescription is required

Semaglutide — the active ingredient in Ozempic, Wegovy, and in compounded semaglutide — is a prescription-only medication. Federal law (the Food, Drug, and Cosmetic Act) restricts dispensing of prescription drugs to those dispensed against a prescription from a practitioner licensed to prescribe, and compounded versions of a prescription drug carry the same prescription requirement.^[1] Compounding does not change a drug's legal status: a compounded semaglutide preparation is still a prescription drug. A state-licensed 503A pharmacy may compound only on receipt of a valid prescription for an individual patient; an FDA-registered 503B outsourcing facility may also fill orders from a health care provider such as a hospital, but that does not create a no-prescription route to a patient.^[3]

In plain terms, there are two non-negotiable people in the chain between you and a legitimate vial of compounded semaglutide: a licensed prescriber who evaluates you and writes the prescription, and a licensed pharmacy that fills it. If a website lets you add semaglutide to a cart and check out with no clinical evaluation and no prescription, it is not a pharmacy operating within the law — and what arrives in the package is, by definition, not a legally dispensed medication.

Where compounded semaglutide stands legally after the shortage

A prescription is necessary, but it is no longer the only hurdle. Much of the 2023–2024 boom in compounded semaglutide relied on the drug being on FDA's shortage list, which lets compounders make copies of an approved product. That window has closed:

• The shortage ended on February 21, 2025. FDA determined that Novo Nordisk's supply could meet present and projected national demand. It gave 503A pharmacies until April 22, 2025, or the date of a court ruling on a pending injunction, whichever came later (the ruling came April 24, 2025), and 503B outsourcing facilities until May 22, 2025, to stop compounding shortage-based copies. A federal court then denied the compounders' request for a preliminary injunction, and FDA confirmed both grace periods have ended.^[6]
• The courts upheld FDA. On August 27, 2026, the U.S. Court of Appeals for the Fifth Circuit affirmed the district court's judgment for FDA and Novo Nordisk in Outsourcing Facilities Association v. FDA, the challenge to the semaglutide shortage decision.^[7]
• 503B bulk compounding is shut off. As of FDA's April 1, 2026 update, semaglutide is neither on the 503B bulks list nor on FDA's drug shortage list, the two routes an outsourcing facility needs to compound from bulk ingredient.^[6]
• "Essentially a copy" is narrowly defined, including B12 blends. A 503A pharmacy may not compound copies of a commercially available drug regularly or in inordinate amounts. FDA's April 1, 2026 clarification says a compounded product that adds another ingredient, such as vitamin B12, can still count as a copy if it is injected and both ingredients are within 10% of the strengths of approved products. The exception is a prescriber's documented determination that a change makes a significant difference for an identified patient. FDA said it does not intend to act against a compounder that fills four or fewer prescriptions of such a product in a calendar month.^[6]
• FDA is targeting mass marketing. On February 6, 2026, FDA announced it intends to restrict GLP-1 active ingredients destined for mass-marketed, non-approved compounded drugs. It also said companies may not call these products generics, the same as FDA-approved drugs, or clinically proven.^[8] On March 3, 2026, it announced 30 warning letters to telehealth companies over false or misleading claims about compounded GLP-1s, including implying sameness with approved drugs.^[9]

What this means for you: a legitimate compounded prescription now depends on a clinician documenting a patient-specific reason the approved product will not work (for example, an allergy to an inactive ingredient or a dose the approved pens cannot deliver), filled by a licensed pharmacy. A site that sells compounded semaglutide in bulk, calls it "generic Wegovy," or skips the clinical step is out of step with FDA's current position. This describes FDA's stated policy, not legal advice, and state pharmacy boards add their own rules.

How the legitimate process actually works

At a legitimate telehealth provider, the flow is consistent and the prescription step is always present. It typically looks like this:

• 1. Online intake / medical questionnaire. You complete a health questionnaire covering your weight, BMI, medical history, current medications, and any conditions that would make semaglutide unsafe. This is the start of a clinical evaluation, not a checkout form.
• 2. Evaluation by a licensed provider. A licensed clinician — a physician, nurse practitioner, or physician assistant — reviews your intake, either in a live telehealth video or phone visit or through an asynchronous (store-and-forward) clinical review. They decide whether semaglutide is appropriate and whether you are eligible.
• 3. A prescription is written — if appropriate. If the clinician determines semaglutide is suitable and you have no disqualifying contraindications, they write a prescription. If it is not appropriate for you, a legitimate provider will decline to prescribe. The prescription is the gate, and it can close.
• 4. The prescription is sent to a licensed compounding pharmacy. A state-licensed pharmacy receives the prescription and prepares the compounded semaglutide. Today that is generally a 503A pharmacy, because semaglutide is not on the list of bulk ingredients 503B outsourcing facilities may use.^[6]
• 5. The medication ships to you. The pharmacy dispenses and ships the medication, usually with cold-chain handling and supplies. Reputable providers also offer follow-up, dose titration support, and a way to report side effects.

The single feature shared by every legitimate path — brand-name and compounded alike — is that a licensed clinician evaluates you and a prescription is written before any medication is dispensed. If you want to see the legitimate workflow end to end, our guide on how to get semaglutide online walks through it, whether you need an ID to buy a GLP-1 online explains the identity-verification step, and the cheapest GLP-1 without insurance buyer's guide covers the legitimate cash-pay channels in cost order.

Red flag: "no prescription needed" and "research-grade" semaglutide

Why these sources are dangerous in concrete terms: "research-grade" or "research peptide" semaglutide has no FDA quality testing behind it — no verified identity, no purity testing, no sterility testing, no endotoxin testing, and no dose-accuracy verification. You cannot know what is actually in the vial, how concentrated it is, or whether it is sterile. Reconstituting and self-dosing an unverified powder is how people end up with dosing errors (FDA has received adverse-event reports, some requiring hospitalization, tied to patients measuring and self-injecting the wrong dose of compounded semaglutide)^[5] and contamination from non-sterile preparation. And because there is no prescriber in the loop, no one has screened you for the contraindications that make semaglutide unsafe for some people.

How to tell a legitimate provider from a gray-market one, drawn from FDA's guidance on buying medicine online safely and its telehealth red-flag list:^[2][5]

• It requires a clinical visit or review. A real provider makes you complete a medical evaluation with a licensed clinician before any medication. If you can buy semaglutide with no health questionnaire, no prescriber, and no prescription, walk away.
• It uses a named, licensed pharmacy. A legitimate provider dispenses through an identifiable U.S. state-licensed 503A pharmacy or an FDA-registered 503B outsourcing facility — not an anonymous overseas "chemical supply" site. You should be able to learn which pharmacy fills your prescription.
• It has a real, licensed prescriber. There is an actual physician, nurse practitioner, or physician assistant who is accountable for the prescribing decision, available for follow-up, and who can decline to prescribe if semaglutide is not right for you.
• It does not advertise "no prescription," "research-grade," or "not for human consumption." Any of those phrases is a stop sign, not a feature.
• It does not call compounded semaglutide "generic" or "the same as Wegovy." Compounded drugs are not FDA-approved and are not generics, and FDA lists sameness claims and too-good-to-be-true prices among its telehealth red flags.^[5][9]

Readers who have confirmed they want a legitimate, prescriber-required provider can use our editorial shortlist below — every provider listed requires a clinical evaluation and a prescription before dispensing.

Why the prescription matters clinically

The prescription requirement is not bureaucratic box-checking — it is the mechanism by which a clinician makes sure semaglutide is safe and appropriate for you specifically. The evaluation a prescriber performs covers several things a checkout cart never could:

• Eligibility screening. A clinician confirms semaglutide is indicated for your situation — for example, an appropriate BMI for weight management, or type 2 diabetes — rather than just selling it to anyone who clicks.
• Contraindications. Semaglutide carries a boxed warning about thyroid C-cell tumors and is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). It is also used with caution in people with a history of pancreatitis and certain other conditions. A prescriber screens for these; a gray-market vendor does not.^[4] See what disqualifies you from semaglutide for the full list.
• Drug interactions. Semaglutide raises the risk of low blood sugar when combined with insulin or a sulfonylurea, and its effect on gastric emptying can affect how other oral medications are absorbed. A prescriber checks your full medication list.
• Dose titration. Semaglutide is started low and stepped up on a schedule to limit gastrointestinal side effects. A prescriber sets and adjusts that schedule; a powder of unknown concentration makes safe titration impossible.
• Monitoring and follow-up. A legitimate prescriber follows up on side effects, kidney function risk from dehydration, and your response — and can pause or stop treatment if needed.

This is the same clinical oversight that stands behind brand-name semaglutide on our Ozempic drug page. The medication is the same molecule; the safety system around it — prescriber evaluation, a licensed pharmacy, titration, and follow-up — is what makes any version of it safe to use, and it is exactly what the "no prescription" sellers strip away.

Bottom line

• Yes, compounded semaglutide requires a prescription. It is a prescription medication; a licensed prescriber (physician, NP, or PA) must evaluate you and write it, and a licensed pharmacy must dispense it.^[1][3]
• There is no legal way to buy real compounded semaglutide without a prescription.
• The semaglutide shortage ended February 21, 2025, and the Fifth Circuit upheld that decision on August 27, 2026. Compounding is now limited to patient-specific prescriptions where a clinician documents a meaningful difference from the approved drug; adding B12 does not automatically qualify.^[6][7]
• Any site selling "no prescription needed," "research-grade," or "not for human consumption" semaglutide is operating outside the law — a major red flag for counterfeit, unverified, or non-sterile product with no clinician oversight and real safety risk.^[2]
• A legitimate provider always requires a clinical visit or review, uses a named licensed pharmacy, and has a real prescriber who can decline to prescribe.
• The prescription exists for clinical reasons: eligibility screening, contraindication checks (MTC/MEN 2, pancreatitis), drug-interaction review, safe dose titration, and monitoring.
• Compare vetted, prescriber-required options on our best semaglutide providers page.

Frequently asked questions